HIF1A and cancer: Analyzing the GOI expression when subgroups were based on the Youden’s J statistic for age, we observed significantly elevated levels of both HIF1A (p = 0.0023) and EPAS1 (p = 0.0246) between controls and cancer patients in the group > 56 yrs.